Amina Zoubeidi

Dr Zoubeidi major research focus is to uncover molecular mechanisms of prostate cancer progression to the castrate-resistant stage and metastatic disease with a special interest on elucidating mechanisms of epithelial mesenchymal transition. She elucidates diverse mechanisms involving stress activated proteins, Hsp27, clusterin, and tyrosine kinases Lyn and Fer in androgen independent progression. She recently developed pre-clinical models of MDV3100 resistant tumors and cell lines and studying mechanisms of resistance to MDV3100. She has an extensive expertise in cell signaling, molecular and cellular biology and in vivo efficacy studies. She holds a Michel Smith Foundation for Health Research, Career development award (2012-2021), a merit award for academic achievement, University of British Columbia (2011), the New Investigator Award, Terry Fox Research Institute (2010-2014),a new Investigator Award, Prostate Cancer Foundation (USA) (2010-2013), and multiple research context awards including first prize, Research award, American Urological Association (2008), first prize, Research award, Northwest Urological Society (2007) and AACR- Brigid G. Leventhal Scholar in Cancer Research Award (2007) and a dean’s honor list, PhD thesis, Université de Montréal (2005) among others.